Internal Medicine, Infectious Disease · Cumming, GA
NPI
1215971668
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
101 Greenfield Dr Ste 100
Cumming, GA, 30040
Phone (678) 786-1314
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.6M
2,089,355 services
Medicare patients, 2024
516
Average age 77
Drug cost, 2024
$493K
856 prescriptions
Company payments, 2025
$962
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Madhavi Rayapudi was code J0878 (injection, daptomycin, 1 mg), 1,913,751 times for 87 patients. In total Madhavi Rayapudi billed 2,089,355 services in 87 codes, and Medicare paid $1.6M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-07-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0878 Injection, daptomycin, 1 mg | Office | 1,913,751 | 87 | $0.04 | $83K |
| J0121 Injection, omadacycline, 1 mg | Office | 71,000 | 30 | $2.96 | $210K |
| J2248 Injection, micafungin sodium, 1 mg | Office | 26,801 | 12 | $0.33 | $8,971 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 15,881 | 92 | $0.36 | $5,707 |
| J7050 Infusion, normal saline solution, 250 cc | Office | 9,436 | 196 | $0.51 | $4,859 |
| J2185 Injection, meropenem, 100 mg | Office | 5,311 | 23 | $0.29 | $1,549 |
| J0713 Injection, ceftazidime, per 500 mg | Office | 5,241 | 27 | $1.30 | $6,794 |
| 96365 Intravenous Infusion, Hydration | Office | 5,054 | 204 | $48.59 | $246K |
| J0875 Injection, dalbavancin, 5 mg | Office | 4,300 | 14 | $12.20 | $52K |
| 99232 Hospital E&M - Subsequent | Facility | 3,066 | 288 | $60.83 | $186K |
| 99214 Office E&M - Established | Office | 2,029 | 341 | $98.14 | $199K |
| 96367 Intravenous Infusion, Hydration | Office | 1,831 | 78 | $21.99 | $40K |
| J1335 Injection, ertapenem sodium, 500 mg | Office | 1,706 | 46 | $9.02 | $15K |
| 96366 Intravenous Infusion, Hydration | Office | 978 | 53 | $15.67 | $15K |
| J3370 Injection, vancomycin hcl, 500 mg | Office | 834 | 14 | $1.84 | $1,536 |
By year: 2022 $1.5M for 1,783,032 services; 2023 $1.6M for 2,525,018 services; 2024 $1.6M for 2,089,355 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 522 | 156 | $8.65 | $4,515 |
| 81000 Clinical Chemistry | 289 | 77 | $3.94 | $1,139 |
Medicare prescription drug claims, 2024
In 2024, the drug Madhavi Rayapudi prescribed most often to Medicare patients was Daptomycin, with 111 prescriptions and refills. In total Madhavi Rayapudi wrote 856 Medicare prescriptions that cost $493K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Daptomycin Generic | 111 | 111 | 20 | $44K |
| Fluconazole Generic | 44 | 49 | 18 | $737 |
| Ceftriaxone Ceftriaxone Sodium | 43 | 43 | 14 | $7,246 |
| Ertapenem Ertapenem Sodium | 40 | 40 | 12 | $17K |
| Ceftazidime Generic | 39 | 39 | Under 11 | $6,889 |
| Trimethoprim Generic | 38 | 47 | 15 | $1,613 |
| Vancomycin Hcl Generic | 36 | 36 | 11 | $2,964 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 33 | 37 | 19 | $729 |
| Minocycline Hcl Generic | 27 | 27 | 18 | $456 |
| Cefdinir Generic | 27 | 27 | 20 | $441 |
| Methenamine Hippurate Generic | 26 | 41 | 12 | $2,058 |
| Doxycycline Monohydrate Generic | 22 | 30 | 15 | $723 |
| Nystatin Generic | 21 | 21 | 13 | $241 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 21 | 21 | 13 | $163 |
| Azithromycin Generic | 21 | 25 | 14 | $91.71 |
Brand drugs: 146 claims; generic drugs: 710 claims; opioid claims: 31.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Madhavi Rayapudi $962 ($962 in general payments such as food, travel and fees) from 17 companies. The largest payer was Pfizer Inc. with $180.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 8 | $180 |
| Cumberland Pharmaceuticals, Inc. CPIX | 10 | $174 |
| Gilead Sciences, Inc. GILD | 5 | $99.11 |
| Abbvie Inc. ABBV | 4 | $98.36 |
| Shionogi Inc 4507.T | 3 | $57.17 |
| MIMEDX Group, Inc. MDXG | 3 | $55.4 |
| Grifols USA, LLC | 2 | $43.57 |
| La Jolla Pharmaceutical Company | 2 | $36.57 |
| ViiV Healthcare Company GSK | 1 | $32.4 |
| Invivyd Inc IVVD | 1 | $30.54 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.